Resultados de la búsqueda 231-240 of 5779 for Phase

  1. Hematología - Ensayos clínicos - Mayo Clinic

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this ...

  2. Oncología (médica) - Ensayos clínicos

    This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Phase I Trial of Sargramostim and Nivolumab for Metastatic Melanoma to the Lung. Rochester, Minn. This phase I trial is looking to see if sargramostim given ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    ... phase II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...